Studies with insulin and sulfonylureas showed a neutral effect on HF, and glucagon-like peptide-1 (GLP-1) agonists/analogs55 and acarbose56 proved to be neutral regarding the risk for HF hospitalizations and mortality. Here, INS is linked to hydrops fetalis.